LitAlert ~~ GeneLit.com

    • Successful treatment of a patient with brain metastasis from ovarian cancer with BRCA wild type using niraparib: A case report and review of the literature.
    • Xu M, Zhang Z, Du X, He H, He W, Li D, Wen Q.
    • Front Oncol. 2022 Apr 4;12:873198. doi: 10.3389/fonc.2022.873198.
    • Chasing the origin of 23 recurrent BRCA1 mutations in Pakistani breast and ovarian cancer patients.
    • Rashid MU, Muhammad N, Naeemi H, Shehzad U, Hamann U.
    • Int J Cancer. 2022 Apr 4. doi: 10.1002/ijc.34016. Epub ahead of print.
    • Cancer in children with biallelic BRCA1 variants and Fanconi anemia-like features: Report of a malignant brain tumor in a young child.
    • Borlin PR, Brazzola P, Frontzek K, Zanoni P, Morscher RJ, Hench J, Frank S, Kottke R, Rushing EJ, Goeggel Simonetti B, Steindl K, Guerreiro Stucklin AS.
    • Pediatr Blood Cancer. 2022 Apr 4:e29680. doi: 10.1002/pbc.29680. Epub ahead of print.
    • Case report
    • Resveratrol sensitizes breast cancer to PARP inhibitor, talazoparib through dual inhibition of AKT and autophagy flux.
    • Pai Bellare G, Sankar Patro B.
    • Biochem Pharmacol. 2022 Mar 30:115024. doi: 10.1016/j.bcp.2022.115024. Epub ahead of print.
    • Federated analysis of BRCA1 and BRCA2 variation in a Japanese cohort.
    • Casaletto J, Parsons M, Markello C, Iwasaki Y, Momozawa Y, Spurdle AB, Cline M.
    • Cell Genom. 2022 Mar 9;2(3):110882. doi: 10.1016/j.xgen.2022.100109.
    • The first European gynaecological procedure with the new surgical robot Hugo™ RAS. A total hysterectomy and salpingo-oophorectomy in a woman affected by BRCA-1 mutation.
    • Monterossi G, Pedone Anchora L, Gueli Alletti S, Fagotti A, Fanfani F, Scambia G.
    • Facts Views Vis Obgyn. 2022 Mar;14(1):91-94. doi: 10.52054/FVVO.14.1.014.